All In Biotech

Drug Trial Radar · NCT00093886

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)

Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Nitroglycerin as Active Comparator) (ECLIPSE-NTG)

Last checked: Nov 20, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 629 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

629

Actual

Start

Apr 2004

Primary completion

Mar 2005

Study completion Apr 2005

Sponsor

Lead sponsor
The Medicines CompanyIndustry
Sponsor type
Industry
First posted
Oct 8, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the safety of clevidipine in the treatment of perioperative hypertension. Approximately 500-900 patients with perioperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or nitroglycerin.

Conditions

  • Hypertension

Interventions

  • clevidipineDrug

  • nitroglycerinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of death, stroke, MI and renal dysfunctionTime frame: Initiation of study drug infusion through post-operative Day 30

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Brookwood Medical Center

    Birmingham, Alabama

  • Baptist Medical Center, Montclair

    Birmingham, Alabama

  • Medical Center East

    Birmingham, Alabama

  • Baptist Medical Center, South

    Montgomery, Alabama

  • University Medical Center

    Tucson, Arizona

  • Saddleback Memorial Medical Center

    Laguna Hills, California

  • Keck School of Medicine, University of Southern California

    Los Angeles, California

  • Huntington Memorial Hospital

    Pasadena, California

  • University of California

    San Francisco, California

  • Regional Medical Center - Bayonet Point

    Hudson, Florida

  • Health First Holmes Regional Medical Center

    Melbourne, Florida

  • Sacred Heart Health System

    Pensacola, Florida

  • Kaiser Permanente Moanalua Medical Center

    Honolulu, Hawaii

  • Saint Francis Hospital

    Evanston, Illinois

  • Wesley Medical Center

    Wichita, Kansas

  • St Joseph Medical Center

    Towson, Maryland

  • Henry Ford Health System

    Detroit, Michigan

  • New York University Medical Center

    New York, New York

  • Sterling Research Group, Ltd.

    Cincinnati, Ohio

  • The Christ Hospital, The Linder Clinical Trial Center

    Cincinnati, Ohio

  • Portland VA Medical Center

    Portland, Oregon

  • Memorial Herman Memorial City Hospital

    Houston, Texas

  • Michael E DeBakey VA Medical Center

    Houston, Texas

  • The Methodist Hospital

    Houston, Texas

  • Houston Northwest Medical Center

    Houston, Texas

  • Inova Fairfax Hospital

    Falls Church, Virginia

  • Virginia Commonwealth University Medical Center

    Richmond, Virginia

  • Saint Joseph Medical Center

    Tacoma, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.